Melanoma Intelligence: Explainable AI Reveals Histopathologic Aggressiveness as the Dominant Axis of Lymph-Node Metastasis
Vlad-Petre Atanasescu, Valentin Titus Grigorean, Raluca Florentina Tulin, Maria Fulina, Matei Șerban, Răzvan-Adrian Covache-Busuioc, Corneliu Toader, Alexandru Vlad Ciurea, Anamaria Oproiu · 2026
Read Melanoma Intelligence: Explainable AI Reveals Histopathologic Aggressiveness as the Dominant Axis of Lymph-Node Metastasis by Vlad-Petre Atanasescu, Valentin Titus Grigorean, Raluca Florentina Tulin, Maria Fulina, Matei Șerban, Răzvan-Adrian Covache-Busuioc, Corneliu Toader, Alexandru Vlad Ciurea, Anamaria Oproiu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13607197.txt.
Description
Vlad-Petre Atanasescu and co-authors present a 2026 study on what drives melanoma spread to lymph nodes. Node spread shapes stage, outlook, and care plans for this skin cancer. Past models weighed tissue traits, blood markers, and clinical facts one at a time. The team built a clear AI tool that weighs all layers at once and asks which layer rules.
The study drew on 73 adults who had melanoma removed by surgery. Data were grouped into scored bundles, led by a tissue aggression index. Node spread, confirmed by tissue tests, was the outcome. The tool's design keeps its reasoning open to view, so doctors can see why a score lands where it does. Early results cast tissue aggression as the lead axis. Clear models may earn a place in staging work.
Catalog record
| CREATOR | Vlad-Petre Atanasescu, Valentin Titus Grigorean, Raluca Florentina Tulin, Maria Fulina, Matei Șerban, Răzvan-Adrian Covache-Busuioc, Corneliu Toader, Alexandru Vlad Ciurea, Anamaria Oproiu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |